A global research collaboration has revealed how certain gut cells switch on pain signals, which can linger long after the initial trigger has passed, potentially contributing to chronic pain in conditions like irritable ...
Feb 14, 2025
0
27
Researchers at Rutgers University-New Brunswick, along with international collaborators, have introduced a novel method for identifying the crucial set of gut microbes commonly found in humans and essential for health.
Oct 16, 2024
0
35
Multiple sclerosis (MS) is a chronic inflammatory disease in which the immune system attacks the central nervous system. This impairs the transmission of signals between the brain and body and can lead to deficits in vision, ...
Sep 30, 2024
0
24
Psoriasis—a chronic skin condition—is not caused or spread by spontaneous genetic mutations in the skin, new research suggests.
Oct 26, 2023
0
86
A study has thrown crucial new light on the relationship between the mental and physical health of people who suffer from three stigmatizing disorders whose symptoms are not medically explained, including chronic fatigue ...
May 30, 2023
0
75
Neurons that sense pain protect the gut from inflammation and associated tissue damage by regulating the microbial community living in the intestines, according to a study from researchers at Weill Cornell Medicine.
Oct 14, 2022
0
108
Mount Sinai researchers have identified genetic and cellular mechanisms of Crohn's disease, providing new insights for future treatments that could offer a tailored approach to patients with the chronic inflammatory disease, ...
Mar 31, 2021
0
76
Multiple sclerosis (MS) is a chronic inflammatory disease that affects the central nervous system, in which nerve cells are attacked by the patient's own immune system. In many cases, the disease develops into a progressive ...
Jan 26, 2021
0
78
Results from a new Cleveland Clinic-led study suggest that melatonin, a hormone that regulates the sleep-wake cycle and is commonly used as an over-the-counter sleep aid, may be a viable treatment option for COVID-19.
Nov 9, 2020
0
6474
Delta opioid receptors have a built-in mechanism for pain relief and can be precisely targeted with drug-delivering nanoparticles—making them a promising target for treating chronic inflammatory pain with fewer side effects, ...
Jun 15, 2020
0
553
